Article Details

EU regulator begins real-time review of GSK-Vir COVID-19 antibody drug

Retrieved on: 2021-05-07 09:18:56

Tags for this article:

Click the tags to see associated articles and topics

EU regulator begins real-time review of GSK-Vir COVID-19 antibody drug. View article details on hiswai:

Excerpt

Sotrovimab belongs to a class of medicines called monoclonal antibodies, which are synthetically manufactured copies of the human body's natural ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo